BALTIMORE, July 9, 2018 – Elixirgen Therapeutics, Inc. raised $4 million in a Series A funding round from University of Tokyo Edge Capital (UTEC). Elixirgen Therapeutics, Inc. is a biotechnology company founded by Minoru Ko, M.D., Ph.D., that is focused on curing humanity’s ailments through innovations in stem cell biology. Elixirgen Therapeutics is pursuing cures […]
BALTIMORE, May 7, 2018 – Elixirgen Therapeutics, LLC has now incorporated to become Elixirgen Therapeutics, Inc. This change makes the company a better target for investment from strategic partners or venture capital, which will in turn help the company to further its goals in developing and commercializing its therapies.